This is the talk page for discussing improvements to the Psychedelic therapy article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
![]() | This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Psychedelic therapy.
|
This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Jakexx360.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 02:49, 18 January 2022 (UTC)
This article was the subject of a Wiki Education Foundation-supported course assignment, between 6 May 2019 and 30 August 2019. Further details are available on the course page. Student editor(s): Caharvey11.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 02:49, 18 January 2022 (UTC)
This article was the subject of a Wiki Education Foundation-supported course assignment, between 14 January 2020 and 10 April 2020. Further details are available on the course page. Student editor(s): Katiefitz18.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 02:49, 18 January 2022 (UTC)
This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Kellynbobellyn.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 07:24, 17 January 2022 (UTC)
An author of the article had given the translation of the word "Psychodelic" as "mind-manifesting". I have corrected that, because the common translation of the ancient greek term "psukhe" (which represents the correct philological-scholarly transcription in latin letters) or "psyche" (which is the commonly used variant in non-scholarly contexts) would certainly be "soul", as in "psycho-logy" = knowledge/study of the soul ! English "mind" one would usually translate for ancient greek "nous".147.142.186.54 (talk) 13:51, 24 November 2007 (UTC)
I "stumbled" over the use of the word "therapy" here, esp. in the sub-section "Psychodelic Therapy".
Now, I am not familiar in any way with "North American practice". I know a little bit about the "psycholytic" method (since I am European), which employed certain drugs - in tiny doses within a professional therapeutic setting - to sort of "dissolve" BARRIERS to gain access to areas or material during a ps.therapeutic session that otherwise seemed "unaccessible" to the conscious of both the patient and the therapist; hence the drug itself would not in any way perform a "healing action", but work as a tool to open a pathway to "hidden chambers", the contents of which could then be dealt with by the humans involved in "conventional ways" (expressing, talking, analysing, clarifying connections to behaviour and symptoms, "working through" [psycho-jargon] etc.). - I find that the article is misleading on this point, because it makes the reader assume that the DRUG is actively "setting things right" in the human (patient's) psyche, which to my knowledge it does not and was not believed to effect. And mind you, that is a fundamental difference: it sounds like "take a pill (albeight one prescribed by a physician) - and 'bingo' you are all right". Like an easy treatment with psychopharmacological drugs, same strategy, same action...
Now by contrast, says the article, elsewhere (i.e. predom. in N.America) high doses are used to provoke or create "ecstatic" experiences and the like. It is not clear to me, and the article does not elaborate in any way, WHY such things would act or contribute to HEAL that patient, and then, what understanding of "healing" might be shared by the proponents of such practices, and on what timescale it is thought to manifest itself - and stay stable - ? etc. With other words, what precisely would set it apart from some person just taking stuff at home on their couch in order to have fun, escape boredom, get a "kick", escape unpleasant emotions, forget their mental and emotional trouble and pain etc. If all sorts of things are supposed to qualify as "therapy", the term looses meaning. If it is to retain its meaning, what makes drug taking while sharing a room with a person who considers himself a "therapist" a "healing" activity ?? - That needs to be explained, because it is the core of the whole topic !
Regards, Sophophilos: 147.142.186.54 (talk) 13:51, 24 November 2007 (UTC)
How can an article entitled "Psychedelic Therapy" have a section called "Psychedelic Therapy"? Myrvin (talk) 12:34, 17 October 2008 (UTC)
The term "politicised regulation" seems derogatory; and I don't see how you can 'contradict' a regulation. Perhaps the sentence should be something like: "The evidence (or argument) supporting this regulation is contradicted...." Myrvin (talk) 12:40, 17 October 2008 (UTC)
I'm revising the page a lot to include citations from the BBC etc. Many of these claimed studies can be sourced, and I genuinely intend to do so. Hence the tags. Feel free to help.:) special, random,Merkinsmum 17:20, 20 March 2008 (UTC)
I edited the current research section as it seemed to lack npov and read like a press release for John Halpern and MAPS. They have been very visible in media accounts of psychedelic research but the extent of their achievements is not clear, since researchers like Rick Strassman and Franz Vollenweider and organizations like the Heffter Research Institute also deserve significant recognition. Human research with hallucinogens has been possible since Strassman established a precedent at the FDA. Many groups in the US and world are now doing human psychedelic work. However, organizations like MAPS have encountered difficulties. I tried to add in an a clear explanation of why that is. --68.167.207.250 (talk) 17:09, 28 June 2008 (UTC)
Here is some current research I'd like to add. I think it gives good insight into the state of research:
More recently, Johns Hopkins University and New York University have conducted large randomized, placebo-controlled studies.[1] These two studies are some of the first large controlled studies measuring the effects of psychedelic therapy on depression and anxiety in cancer patients[1] . Across clinician-ratings and self-ratings, the psychedelic treatment produced statistically significant lowered anxiety and depression, with sustenance for at least 6 months.[2][3] Importantly, adverse effects from the drugs were not noted [2][3].
Both studies also attributed the efficacy in part to patients experiencing a “mystical experience” [2][3]. A mystical experience is a very personal introspective experience where some sort of unity or transcendence of time and space is described.[4] More research is necessary to expand generalizability of the conclusions. Also, more research is necessary to understand the biological properties of a mystical experience[3]. --Erm253 (talk) 13:58, 18 November 2019 (UTC)erm253
References
((cite journal))
: |access-date=
requires |url=
(help)
((cite journal))
: |access-date=
requires |url=
(help); Check date values in: |date=
(help)
Efforts to utilize the purely pharmacological properties of LSD and other drugs in psychedelic treatment were completely abandoned after it was realized that they had no direct chemotherapeutic curative properties. Rather, it is through the unique introspective state attained by the patient (with the drug as a ‘catalyst’), in combination with a positive, empathetic relationship with an experienced psychotherapist, that the actual ‘healing’ can occur.
I have decided to tag this article with ((medref)) because it relies too heavily on primary sources.
WP:MEDRS says: "Ideal sources for biomedical material include general or systematic reviews in reliable, third-party, published sources, such as reputable medical journals, widely recognised standard textbooks written by experts in a field, or medical guidelines and position statements from nationally or internationally recognised expert bodies." (Emphasis mine.)
Please see also the sentence of WP:MEDRS#Avoid over-emphasizing single studies, particularly in vitro or animal studies which begins with the words "Use of small-scale, single studies make for weak evidence".
Cheers, —Unforgettableid (talk) 03:18, 14 January 2014 (UTC)
According to the accounts of Grof and Halifax, a pediatrician named Valentina Pavlovna Wasson, was intrigued by the use of psychedelic mushrooms by Mexicans. She further turned out to be the first recorded Westerner to be admitted into a “sacred ritual led by a medicine woman”. The use of psychedelic mushrooms was supposedly a natural characteristic of the Columbian cultures, and it had spread wide across Central America. After the use of this substance, the effect of the mushrooms left a great impression upon Valentina. She later revealed that these magic mushrooms could be put into use for deep psychic experiences and even other various medical/therapeutic uses. These mushrooms are identified as Psilocybe mexicana (Psylocybin).[1]
Nonetheless, before the West had the begun its deep research and experiments into the benefits of psychedelic therapy, the use of these psychedelic plants were referred as mystical healing powers across most ancient cultures. It became a tradition to use these plants for all their communal rituals. It would be involved in death mostly, helping those in pain transition into the next dimension. This transition would be a part of a shared experience, as the “shaman or the wise leader would ingest these psychedelic plants or would make the group do so” in order to conduct the ritualistic process properly. Psilocybin, marijuana and mescaline were commonly practiced for these spiritual experiences. The active psychedelic properties of most of these hallucinogenic plants came under the inspection of Western scientists only recently.[1]
Sizeofint (talk) 15:48, 12 March 2015 (UTC)
References
((cite journal))
: CS1 maint: unflagged free DOI (link)
I need ideas on how to improve this article.
Kellynbobellyn (talk) 22:24, 22 February 2017 (UTC)
PBIO4181J Evaluation: Overall the article is organized into sections that all relate to the topic itself, but it could be organized better. There is a history section right when the article begins and another section about history at the end. Those two sections should be closer together in the article to make it more understandable. The topic is not fully covered and there is a lack of information on the subject. The article only covers the use of psychedelic therapy with regards to alcoholism and terminal illnesses. To improve the quality and information it would be best to add in the use of psychedelic therapy as treatment for addiction as a whole, illnesses like depression and anxiety, and server or chronic pain. This is especially important because in the history portion of the article it is stated that psychedelic therapy can be used to treat PTSD, depression, alcoholism, and cluster headaches, so information should be added regarding each. Kellynbobellyn (talk) 14:20, 16 March 2017 (UTC) Another organization mistake is putting the 'restrictive regulation' section towards the end. The section explains that psychedelic therapy was at a standstill for awhile because of government laws on the psychoactive drugs. This section would be more appropriate towards the beginning of the article because it is apart of the topic's history and does no good to read it at the very end. The article is also written in chunks and doesn't flow well. For example, this first section is broken into eight mini paragraphs with ideas that jump around. Overall the writing and ideas of the article are very scattered and jumbled. It is also a good idea to state the importance and recent concern for psychedelic therapy, so readers understand why this topic is being written about. The article begins with an introduction that gives a brief overview on psychedelic therapy. It could be rewritten to emphasize the main points of the article rather only describing the psychoactive drugs used and how the therapy sessions work. It ends with information about a previous study done, which I think would be more appropriate in a section dedicated to prior research. The article has many headings and subheadings which is good, but there are no images or diagrams shown. Adding images and figures from previous studies to show how psychedelic therapy as helped people should be done. The overall coverage of the article is very neutral and unbiased. The article explains the positive effects psychedelic therapy has had on people and also highlights an opposing view. Lastly, the references are all reliable and good sources of evidence, but more citations are needed. It is not good to have facts presented with no citation afterwords. One problem with some of the references is that you aren't able to be redirected to them. This makes it hard to tell if the information presented actually came from that reference. Kellynbobellyn (talk) 16:44, 17 March 2017 (UTC)
I have restructured the bulk of the page to make more sense. I isolated information about its history to a single sequential section. I removed information about the applications of therapy from the history section to its own Applications section. I also added a significant amount of information about studies conducted after 2000, which the original page lacked almost completely.
In the near future, I plan to review/revise the opening summary, Methods section, and Applications section to make sure each is written in a non-biased fashion and that all claims are cited. Additionally, I would like to add a "PTSD" subheader underneath the new Applications section and attempt to fill in some information. I want to add more information to the new "Early Psychedelic Therapy" subheader.
Jakexx360 (talk) 17:31, 7 November 2018 (UTC)
Thanks! I have cleaned up the intro paragraph to be substantially shorter and more to the point. It had a lot of bad and pointless information in it originally. I don't think I'll have time to add the `PTSD` subheader in the `Applications` section, however that is a perfect location for anyone who wants to contribute to add any of the huge wealth of PTSD-related studies (utilizing MDMA) that have occurred since the early 2000s. That is likely the most relevant information somebody would be looking for when they visit this page.
Jakexx360 (talk) 18:59, 30 November 2018 (UTC)
February 25th, 2020 Katie Thorne I am going to be doing some work on this page over the next few weeks. I am going to be adding to some sections and updating some with more recent research. Once I have completed editing it I will spell out what I changed exactly.
I can find a lot of hype and claims on this topic but there is no evidence. Research about it is biased: small sample groups, no randomization, lack of long term observation etc. [1] [2] [3] [4] [5] [6]
I think this page should be thoroughly revised and corrected, highlighting the evidence we have on "Psychedelic therapy". Digressivo (talk) 10:47, 11 August 2020 (UTC)
References
((cite journal))
: CS1 maint: unflagged free DOI (link)
((cite journal))
: Check date values in: |date=
(help)
He tenido experiencias propias con referente al tema watherlobo21@gmail.com 181.203.24.134 (talk) 00:09, 27 May 2022 (UTC)
I see no mention of risks or side effects. Today's New York Times has a balanced article summarizing what's known, both potential benefits and risks; see [1]. NightHeron (talk) 11:45, 16 December 2022 (UTC)
This article was the subject of a Wiki Education Foundation-supported course assignment, between 11 January 2023 and 5 May 2023. Further details are available on the course page. Student editor(s): Liviaamurphy444 (article contribs). Peer reviewers: Gksanders, Amcsparkplug.
— Assignment last updated by Jessicacariello (talk) 14:57, 14 February 2023 (UTC)
This article was the subject of a Wiki Education Foundation-supported course assignment, between 2 January 2023 and 30 June 2023. Further details are available on the course page. Student editor(s): Td1678 (article contribs).
— Assignment last updated by JustinxLane (talk) 19:04, 2 June 2023 (UTC)
This article was the subject of a Wiki Education Foundation-supported course assignment, between 7 September 2022 and 1 January 2023. Further details are available on the course page. Student editor(s): Td1678 (article contribs).
— Assignment last updated by JustinxLane (talk) 19:44, 26 May 2023 (UTC)
A recent edit [2] concerning psychedelic therapy and domestic violence is sourced to PsyPost [3], a website that says it is "dedicated to reporting on latest research". I don't think its use in this article is compliant with WP:PRIMARY and WP:MEDRS, but I'd like to know what others think. Thanks. NightHeron (talk) 07:13, 11 October 2023 (UTC)
It is a form of LSD (lysergide d-tartrate) designated as MM120, is being developed by biopharma company MindMed as a treatment for general anxiety disorder (GAD).
I'm not a seasoned Wikipedia editor but thought I'd add this to the talk page as I think it would be notable for inclusion 134.134.139.78 (talk) 15:53, 15 March 2024 (UTC)
You just reverted my changes saying that the source is not reliable, however our source is reliable and our articles have also extra sources.
I believe that you should look more indepth into what do you consider reliable or not, becasue right now this piece of information has sources such as:
http://protest-muenchen.sub-bavaria.de/artikel/466
Do you consider this a Reliable Source ? a website in german which is not even secure? Compared to a website which cite sources on their articles. Mariaioana234 (talk) 09:40, 5 July 2024 (UTC)
An interesting article on psychedelic therapy appeared today: [4]. The author, science writer Caty Enders, writes: "I was for a long time a psychedelic proponent, bullish on the idea that a once-illicit treatment could have widespread benefits for the many who are suffering. But through my own experience in the psychedelic community and proximity to the science of psychedelic therapy, I’ve come to realize that the field is plagued with poor clinical trial design and questionable practices that have led researchers and clinicians to premature confidence in what psychedelics can do. The recent F.D.A. decision has added to my concern that Western medicine’s promotion of psychedelics might have oversold hope to the most vulnerable among us, while fueling an industry that was once projected to be worth over $7 billion by 2029." Perhaps her observations can be used in the article. NightHeron (talk) 11:06, 24 August 2024 (UTC)